Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 16 studies | 39% ± 14% | |
| peripheral blood | 16 studies | 34% ± 11% | |
| intestine | 9 studies | 33% ± 18% | |
| kidney | 8 studies | 38% ± 15% | |
| eye | 6 studies | 31% ± 17% | |
| uterus | 6 studies | 56% ± 13% | |
| liver | 5 studies | 26% ± 7% | |
| bone marrow | 4 studies | 20% ± 6% | |
| prostate | 4 studies | 32% ± 5% | |
| skin | 4 studies | 45% ± 11% | |
| lymph node | 4 studies | 39% ± 16% | |
| breast | 4 studies | 58% ± 13% | |
| ovary | 3 studies | 41% ± 15% | |
| adrenal gland | 3 studies | 36% ± 10% | |
| esophagus | 3 studies | 39% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 98% | 15380.14 | 640 / 653 | 99% | 154.33 | 601 / 605 |
| breast | 99% | 14238.03 | 453 / 459 | 98% | 103.32 | 1092 / 1118 |
| kidney | 99% | 12430.30 | 88 / 89 | 95% | 125.02 | 860 / 901 |
| liver | 96% | 15041.32 | 216 / 226 | 98% | 149.32 | 399 / 406 |
| lung | 99% | 21109.03 | 572 / 578 | 93% | 73.20 | 1078 / 1155 |
| prostate | 74% | 5619.03 | 182 / 245 | 99% | 157.77 | 499 / 502 |
| bladder | 86% | 6623.38 | 18 / 21 | 83% | 58.36 | 418 / 504 |
| skin | 96% | 9781.43 | 1732 / 1809 | 69% | 31.15 | 327 / 472 |
| stomach | 78% | 9100.36 | 281 / 359 | 79% | 40.41 | 225 / 286 |
| uterus | 62% | 4356.32 | 105 / 170 | 93% | 67.46 | 425 / 459 |
| adrenal gland | 71% | 4509.51 | 184 / 258 | 82% | 86.17 | 189 / 230 |
| ovary | 69% | 9163.97 | 125 / 180 | 81% | 44.08 | 350 / 430 |
| esophagus | 69% | 5323.37 | 1004 / 1445 | 80% | 41.27 | 146 / 183 |
| intestine | 72% | 8992.84 | 698 / 966 | 76% | 37.32 | 400 / 527 |
| pancreas | 48% | 3126.96 | 157 / 328 | 97% | 117.78 | 173 / 178 |
| brain | 38% | 2933.40 | 1009 / 2642 | 95% | 116.64 | 672 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 106.24 | 29 / 29 |
| blood vessel | 100% | 30058.93 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 18639.00 | 1189 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 95% | 11698.70 | 880 / 929 | 0% | 0 | 0 / 0 |
| spleen | 92% | 5114.90 | 221 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 89% | 41.71 | 40 / 45 |
| heart | 78% | 11075.37 | 675 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 59% | 16.87 | 47 / 80 |
| muscle | 28% | 1888.60 | 226 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006915 | Biological process | apoptotic process |
| GO_0030154 | Biological process | cell differentiation |
| GO_0043065 | Biological process | positive regulation of apoptotic process |
| GO_1900745 | Biological process | positive regulation of p38MAPK cascade |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0046330 | Biological process | positive regulation of JNK cascade |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005515 | Molecular function | protein binding |
| Gene name | GADD45B |
| Protein name | Growth arrest and DNA-damage-inducible beta Growth arrest and DNA damage-inducible protein GADD45 beta (Myeloid differentiation primary response protein MyD118) (Negative growth regulatory protein MyD118) Growth arrest and DNA damage inducible beta |
| Synonyms | MYD118 |
| Description | FUNCTION: Involved in the regulation of growth and apoptosis. Mediates activation of stress-responsive MTK1/MEKK4 MAPKKK. |
| Accessions | ENST00000587887.5 K7EM97 O75293 Q6IX74 ENST00000587345.1 ENST00000585359.1 ENST00000593043.1 ENST00000215631.9 K7EPQ8 |